Proton Pump Inhibitors Market: How Are Eosinophilic Esophagitis and PPIs Intersecting?
Eosinophilic esophagitis and PPI therapy — the evidence for PPI-responsive eosinophilic esophagitis and PPIs as first-line therapy for a subset of EoE patients — represents an evolving and commercially important interaction between the PPI market and the growing EoE therapeutic market, with the Proton Pump Inhibitors Market reflecting EoE as an emerging PPI indication....
0 Commentaires 0 Parts 34 Vue 0 Aperçu